REF
CRI

RAUCH STACEY

Known title: DirectorCIK: 0001511425

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

Cramer Says Reformation’s Stock Should Be Higher Than Price. Jim Cramer noted that Reformation’s shares appear undervalued, suggesting the price should be higher than the current level. The stock trades near the lower end of its 52‑week range and sits below the average analyst target of $19.25. The RSI of 38.0 indicates a neutral stance. No other recent company news directly impacted the stock.

this person other insiders at REF

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

Carter's Stock Faces Slip and Lowered Price Target. Recent coverage notes that Carter's shares fell sharply, prompting a price target reduction to $30 by Wells Fargo. Analysts highlighted warning signs in the Russell 2000 and described the stock as potentially undervalued after a 60% decline. The company’s dividend yield of 4.4% and low P/E of 5.9 are cited as attractive income features, while the stock trades near its $37.59 support level.

this person other insiders at CRI

Transaction History

REF▲ Buy$0
CRI▲ Buy$0
CRI▲ Buy$0
CRI▲ Buy$0
CRI▲ Buy$0
CRI▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.